CD274 and neoplasm: Complementary studies show that tumors with an SP profile dynamically regulate PD-L1, and where SP140 is present, PD-L1 levels on tumor-associated macrophages facilitate immunosuppression and predict responses to anti-PD-1/PD-L1 therapies [38].